期刊文献+

仿制药注射剂处方工艺研究中的相关技术要求 被引量:2

Technical requirements of the research on formula and preparation process of the generic drug product
原文传递
导出
摘要 仿制药目前在我国研发药品总量中占主导地位,与新药一起为公众健康用药提供了有力的保障。仿制注射剂作为很重要的一类仿制药,基于给药途径而对其质量提出更高要求。文中结合"质量一致性"原则,对现阶段仿制注射剂在处方工艺研究中需要关注的几个技术要求进行了归纳与分析,以期促进仿制药评价体系的不断完善,提高评价水平;也引导药品研发者有的放矢,提高研发效率。 Generic drug is a main component of all drug products in China,and ensures the safe use by the public together with innovative drug.The generic injection is the most important type in all generic drugs because its route of administration needs the highest requirement of quality control than any others.In order to further improve our generic drug evaluation system and the quality of our evaluation and to enhance the efficiency of drug research and development,this article points out some requirements on preparation research of generic injection based on the principle of "The quality coherence between the innovative and the generic drug".
作者 吕东 黄文龙
出处 《中国新药杂志》 CAS CSCD 北大核心 2010年第7期561-563,572,共4页 Chinese Journal of New Drugs
关键词 仿制药 注射剂 处方工艺研究 质量一致性 generic drug injection formula and process of preparations research quality coherence
  • 相关文献

参考文献6

二级参考文献15

  • 1叶瑛瑛主著.药品生产验证指南[M].北京:中国医药科技出版社,1996.226.
  • 2化学药物制剂研究基本技术指导原则[S].2005.
  • 3ICH Q8 Pharmaceutical Development[ S]. 2006.
  • 4Qs( RI ) Pharmaceutical Development Revision 1 [ S]. 2008.
  • 5ICH Q9 Quality Risk Managemen[ S]. 2006.
  • 6ICH Q10 Pharmaceutical Quality System[ S]. 2008.
  • 7FDA Draft Guidance Document ANDAs: Impurities in Drug Products[S]. 2005.
  • 8KOVALESKI J, KRAUT B, MATTIUZ A,et al. Impurities in generic pharmaceutical development [ J ]. Adv Drug Del Rev, 2007, 59(1) :56 -63.
  • 9BASAK AK, RAW AS, AI HAKIM AH,et al. Pharmaceutical impurities: regulatory perspective for abbreviated new drug applications [ J ]. Adv Drug Del Rev,2007,59 (1) :64 -72.
  • 10SFDA.药物研究技术指导原则[S].北京:中国医药科技出版社.2006:28-37.

共引文献21

同被引文献17

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部